Does low LV mass (cardiac wasting) predict poor functional status and increased all-cause mortality in patients with advanced cancer?
Low LV mass provides clinical evidence of a cardiac wasting-associated cardiomyopathy that worsens prognosis and functional status in advanced cancer.
Low LV mass is associated with poor functional status and increased all-cause mortality in cancer. These findings provide clinical evidence of cardiac wasting-associated cardiomyopathy in cancer.
Lena et al. (Sat,) studied this question.